קם-רהו די I.M

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

ANTI-D IMMUNOGLOBULINS

Dostępny od:

KAMADA LTD, ISRAEL

Kod ATC:

J06BB01

Forma farmaceutyczna:

תמיסה להזרקה

Skład:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Droga podania:

תוך-שרירי

Typ recepty:

מרשם נדרש

Wyprodukowano przez:

KAMADA LTD, ISRAEL

Grupa terapeutyczna:

ANTI-D (RH) IMMUNOGLOBULIN

Dziedzina terapeutyczna:

ANTI-D (RH) IMMUNOGLOBULIN

Wskazania:

Pregnancy/other obstetric conditions, Suppression of Rh immunization in non-sensitized Rh0 (D) negative women delivering an Rh0 positive baby or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. Kam Rh0 -D IM should be given within 72 hours of the event. It may be given even after up to one month although efficacy may be somewhat reduced.Transfusion: Suppression of Rh isoimmunization in Rh0 (D) antigen-negative patients transfused with Rh0 (D) antigen-positive RBCs of blood components containing Rh0 (D) antigen-positive RBCs . Initate treatment within 72 hours of exposure.

Data autoryzacji:

2022-01-31